Nautilus Biotechnology Stock (NASDAQ: NAUT) stock price, news, charts, stock research, profile.
Open | $2.90 |
Close | - |
Volume / Avg. | 143.20K / 74.36K |
Day Range | $2.87 - $3.05 |
52 Wk Range | 2.19 - 3.62 |
Market Cap | $376.23M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 68 |
Short Interest | 2.83% |
Days to Cover | 21.11 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nautilus Biotechnology (NASDAQ:NAUT) through any online brokerage.
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Quanterix (NASDAQ:QTRX).
Nautilus Biotechnology has a consensus price target of $4.25.
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $3 last updated September 20, 2024 at 12:02 PM EDT.
There are no upcoming dividends for Nautilus Biotechnology.
Nautilus Biotechnology’s Q3 earnings are confirmed for Tuesday, October 29, 2024.
There is no upcoming split for Nautilus Biotechnology.
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.